Sih Partners, Lllp Neurocrine Biosciences Inc Transaction History
Sih Partners, Lllp
- $2.69 Trillion
- Q2 2025
A detailed history of Sih Partners, Lllp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sih Partners, Lllp holds 3,083 shares of NBIX stock, worth $429,862. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,083
Previous 7,511
58.95%
Holding current value
$429,862
Previous $831 Million
53.35%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.37 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$776 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$623 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$430 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...